| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 3074F |
|
363 |
332 |
$0.00 |
| 82728 |
|
359 |
354 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,848 |
1,576 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,075 |
1,736 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
804 |
742 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
792 |
772 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,692 |
1,668 |
$0.00 |
| 1220F |
|
40 |
39 |
$0.00 |
| 82043 |
|
324 |
320 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,479 |
3,627 |
$0.00 |
| 99443 |
|
190 |
186 |
$0.00 |
| 86780 |
|
155 |
153 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
28 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
383 |
379 |
$0.00 |
| 85027 |
|
631 |
571 |
$0.00 |
| 81000 |
|
15 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
562 |
557 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
276 |
274 |
$0.00 |
| 81001 |
|
226 |
210 |
$0.00 |
| 86141 |
|
65 |
63 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,140 |
1,118 |
$0.00 |
| 83550 |
|
274 |
272 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
153 |
149 |
$0.00 |
| 82607 |
|
107 |
104 |
$0.00 |
| 85652 |
|
29 |
27 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
135 |
133 |
$0.00 |
| 83735 |
|
435 |
299 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
57 |
56 |
$0.00 |
| 86706 |
|
37 |
37 |
$0.00 |
| 1111F |
|
92 |
86 |
$0.00 |
| 99441 |
|
37 |
37 |
$0.00 |
| 90686 |
|
66 |
66 |
$0.00 |
| 3044F |
|
186 |
185 |
$0.00 |
| 90656 |
|
31 |
31 |
$0.00 |
| 87340 |
|
67 |
66 |
$0.00 |
| 3075F |
|
44 |
43 |
$0.00 |
| 82746 |
|
12 |
12 |
$0.00 |
| 99442 |
|
829 |
794 |
$0.00 |
| 82540 |
|
324 |
320 |
$0.00 |
| 86705 |
|
12 |
12 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,398 |
1,794 |
$0.00 |
| 86480 |
|
257 |
253 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
139 |
134 |
$0.00 |
| 80061 |
Lipid panel |
1,356 |
1,339 |
$0.00 |
| 77062 |
|
28 |
28 |
$0.00 |
| 82274 |
|
24 |
24 |
$0.00 |
| 3078F |
|
450 |
411 |
$0.00 |
| 86703 |
|
396 |
394 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
135 |
133 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
80 |
78 |
$0.00 |
| 85610 |
|
120 |
92 |
$0.00 |
| 91300 |
|
73 |
70 |
$0.00 |
| 82570 |
|
31 |
30 |
$0.00 |
| 83540 |
|
293 |
290 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
29 |
29 |
$0.00 |
| 84439 |
|
12 |
12 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26 |
12 |
$0.00 |
| 3077F |
|
17 |
15 |
$0.00 |
| 90661 |
|
14 |
14 |
$0.00 |